ANTICANCER COMPOSITIONS

The present invention concerns pharmaceutical formulations of abiraterone acetate and ARN-509, which can be administered to a mammal, in particular a human, suffering from an androgen receptor (AR)-related disease or condition, in particular cancer, more in particular prostate cancer, including but...

Full description

Saved in:
Bibliographic Details
Main Authors MENSCH, Jurgen, BERTELS, Johny
Format Patent
LanguageEnglish
Published 29.11.2018
Subjects
Online AccessGet full text

Cover

Loading…